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Many neurodegenerative disorders, although related by their destruction of brain function, display remarkable cellular
and/or regional pathogenic specificity likely due to a deregulated functionality of the mutant protein. However,
neurodegenerative disease genes, for example huntingtin (HTT), the ataxins,t h epresenilins (PSEN1/PSEN2) are not simply
localized to neurons but are ubiquitously expressed throughout peripheral tissues; it is therefore paramount to properly
understand the earliest precipitating events leading to neuronal pathogenesis to develop effective long-term therapies.
This means, in no unequivocal terms, it is crucial to understand the gene’s normal function. Unfortunately, many genes
are often essential for embryogenesis which precludes their study in whole organisms. This is true for HTT, the b-
amyloid precursor protein (APP) and presenilins, responsible for early onset Alzheimer’s disease (AD). To better
understand neurological disease in humans, many lower and higher eukaryotic models have been established. So the
question arises: how reasonable is the use of organisms to study neurological disorders when the model of choice does
not contain neurons? Here we will review the surprising, and novel emerging use of the model organism Dictyostelium
discoideum, a species of soil-living amoeba, as a valuable biomedical tool to study the normal function of
neurodegenerative genes. Historically, the evidence on the usefulness of simple organisms to understand the etiology
of cellular pathology cannot be denied. But using an organism without a central nervous system to understand
diseases of the brain? We will first introduce the life cycle of Dictyostelium, the presence of many disease genes in the
genome and how it has provided unique opportunities to identify mechanisms of disease involving actin pathologies,
mitochondrial disease, human lysosomal and trafficking disorders and host-pathogen interactions. Secondly, I will
highlight recent studies on the function of HTT, presenilin g-secretase and Hirano bodies conducted in Dictyostelium.I
will then outline the limitations and future directions in using Dictyostelium to study disease, and finally conclude that
given the evolutionary conservation of genes between Dictyostelium and humans and the organisms’ genetic
tractability, that this system provides a fertile environment for discovering normal gene function related to
neurodegeneration and will permit translational studies in higher systems.
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Review
Dictyostelium - emergence of a classic model organism for
the study of neurodegenerative disease
Dictyostelium discoideum is a species of soil-living
amoeba belonging to the Kingdom Amoebozoa and phy-
lum Mycetozoa. Dictyostelium,o rs o c i a la m o e b a ,i sa
eukaryote that when starved, transitions from individual,
self-sustainable professional phagocytes into a highly
coordinated developmental program (Figure 1a). During
this period of multicellular development, the cells exe-
cute a series of morphological changes that proceed in
defined stages over a 24 h period to form a bona fide
multicellular organism. During the earliest developmen-
tal stage, cells secrete, and undergo chemotaxis toward
cyclic adenosine monophosphate (cAMP) to form aggre-
gation territories. The secretion of cAMP promotes a G
Correspondence: myre@chgr.mgh.harvard.edu
Molecular Neurogenetics Unit, Center for Human Genetic Research,
Department of Neurology, Massachusetts General Hospital, Boston, MA
02114, USA
Myre Journal of Biomedical Science 2012, 19:41
http://www.jbiomedsci.com/content/19/1/41
© 2012 Myre; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Figure 1 T h el i f ec y c l eo fDictyostelium discoideum. (A) Most of its life exists in its growth phase, as a haploid social amoeba preying upon
bacteria in the soil and dividing by mitosis. Once the food source is depleted cells enter into a 24 h multicellular developmental program.
During this transition, amoebae aggregate towards secreted cAMP by chemotaxis in the thousands to form a tight mound and then enter a
stage where cells begin to differentiate. Cells within the mound remain motile and are directed to differentiate, by secreted morphogens, into
either prestalk or prespore cells, culminating to form a fruiting body comprised of a multicellular stalk that supports a ball of encapsulated
dormant spores. (B) Scanning electron microscopy showing the various structures formed during development. Permissions: CC Creative
Commons Attribution - Share Alike 3.0, David Brown & Joan E. Strassmann. SEM courtesy of MJ Grimson & RL Blanton, Biological Sciences
Electron Microscopy, Texas Tech University.
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in the formation of discrete mounds containing as many
as 100,000 cells [1,2]. Cells within the mound remain
motile and are directed to differentiate into either pre-
stalk or prespore cells, leading to morphogenetic
changes yielding a multicellular stalk, supporting a ball
of encapsulated dormant spores [3]. The entire process
is clearly depicted in Figure 1b by scanning electron
microscopy and although the life cycle appears simplis-
tic, the entire process is complex with still many unre-
solved questions including how do cells secrete cAMP,
regulate organism size, and initiate cell-fate choices to
n a m eb u taf e w .N e v e r t h e l e s s ,i ti sb e c o m i n gc l e a r e r
that Dictyostelium possesses signal-transduction path-
ways that are closely related to metazoans. Yet, with at
least one major and exploitable fundamental difference:
when animals undergo embryogenesis, they develop
through coordinated cell division, morphogenetic move-
ments and differentiation followed by growth of the
organism. In contrast, Dictyostelium growth precedes
development. This simplifies developmental studies and
provides a novel route to examine with exceptional cel-
lular clarity biological functions including cytokinesis,
endocytosis, secretion, protein trafficking, intra- and
extracellular signaling, gene expression, cell-cell commu-
nication, adhesion, differentiation and many biochemical
aspects of cell motility. With the sequencing of the gen-
o m ec o m p l e t e[ 4 ]w ea r ee n t e r i n gar e n a i s s a n c ei nt h e
use of this organism as a biomedical research tool. Bac-
teria, yeasts and several other invertebrate or vertebrate
model systems are known for their contribution to our
understanding of basic biology and human disease, but
Dictyostelium, unfortunately is rarely included among
this list. Upon publication of the genome, public avail-
ability of RNA seq and DNA microarray data, research
using Dictyostelium has revealed many common cellular
features shared across various phyla, and that many
genes encode for proteins more similar to their human
counterparts than are those of yeasts (Saccharomyces
cerevisiae) [4,5]. Yeasts are single, free-living cells that
reproduce by budding, whose genome consists of 6,000
genes. Similar to Dictyostelium, experiments can be per-
formed over hours, days or weeks whereas in mice these
experiments might take years, if at all possible. More-
over, unlike yeasts, the 34 Mb, Dictyostelium genome is
densely populated with 12, 646 genes and is surprisingly
close in size to the 13,676 genes found in the Drosophila
genome [6]. The fly, unlike Dictyostelium,i sam u l t i c e l -
lular animal with more complex behaviors and nervous
system with a lifespan of 2-3 months and generational
time of 10 days. Worms (Caenorhabditis elegans), also
multicellular contains more genes (19,099) than Dictyos-
telium or the fly, a generation time of 3 days and life-
span of 2-3 weeks. Despite their obvious differences,
relatively low cost compared to mice, and way of life,
importantly, all of these model organisms make proteins
that carry out the same core functions as in humans
and thus might offer clues to pathogenic processes.
Whereas higher eukaryotes often express a number of
similar genes with redundant functions, Dictyostelium,
due to its haploid genome often carries only a single
homologous gene making genetic manipulation by tar-
geted gene deletion simple, quick and at a fraction of
the cost of higher eukaryotes. A quick scan of the gen-
ome reveals many genes that cause neurological disease
including, but not limited to adrenoleukodystrophy
(ABCD1), amyotrophic lateral sclerosis (SOD1), Miller-
Dieker lissencephaly (LIS1), Parkinson’s disease
(UCHL1) and Neuronal ceroid lipofuscinosis (PPT1,
CLN2, CLN3, CLN5) [4]. A conservative search (thresh-
old value of e ≤ 10
-40), detected 64 proteins involved in
human diseases [4]. However, searches using advanced
programs reveal many orthologous proteins that cause
disease (e.g., PSEN1, PSEN2, HTT, Neurofibromatosis 1,
LRRK2) such that the number of predicted human dis-
ease genes in Dictyostelium is greater than previously
thought [7-11]. What I hope to convince you of in this
short review is the importance of using all available
model systems, and posit that, despite its’ evolutionary
distance, reverse genetics in Dictyostelium offers great
promise for translational studies aimed at understanding
the earliest events leading to neurodegeneration.
Alzheimer’s disease: The amyloid precursor protein and
discovery of presenilin-dependent g-secretase activity
Alzheimer’s disease (AD) is the most common cause of
dementia, estimated to contribute to about 60 to 70% of
cases [12]. AD is a terminal disease that culminates in
death. Impaired recent memory usually is an initial
symptom of AD, but other cognitive deficits (e.g.,
changes in attention, problem-solving abilities) may also
be present. Amyloid plaques and neurofibrillary tangles,
the characteristic pathological hallmarks of AD, are
believed to be causative and accrue in the years preced-
ing clinical symptoms. Amyloid plaques are accumula-
tions of insoluble protein aggregates in the extracellular
space of the brain and the primary component of pla-
ques is the Ab peptide, a 38- to 43-amino acid peptide
derived from the larger pre-cursor protein APP [13,14].
Mutations in APP [15,16] and two other genes, preseni-
lin-1 (PSEN1) [17] and presenilin-2 (PSEN2), have been
identified that result in autosomal dominant forms of
early-onset FAD [18]. The intimate relationship between
APP and the presenilins in the production of Ab is
beyond the scope of this review but is detailed elsewhere
[19]. The presenilins are homologous, ubiquitously
expressed multiple transmembrane domain proteins and
many seminal reports provide compelling evidence that
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[20-23]. The protein composition of the g-secretase
complexes have been resolved and each consist of four
proteins that are all required for proteolytic activity
[24-26]: APH-1, PEN2, and nicastrin [25,27]. The nor-
mal biological function of the presenilins has been diffi-
cult to determine largely due to the fact that it is
essential and knockout mice die in utero. To fully
understand and appreciate the normal in vivo function
of the presenilins they must be studied in the context of
organismal models including Dictyostelium.
The identification of presenilins and g-secretase activity in
Dictyostelium
A recent development in Dictyostelium biomedical
research was the identification of homologous genes to
presenilin 1, presenilin 2, nicastrin, aph-1 and pen-2,t h e
core components that constitute the g-secretase complex
[8]. In humans, mutations in the presenilins are inti-
mately involved in the aberrant proteolytic processing of
APP in a pathway leading to FAD. How the mutations
cause disease, or more importantly the time course or
precipitating events that lead to the pathogenesis of AD
are not known, and as such, highlight the importance of
uncovering the normal function of the g-secretase com-
plex. In this respect, Dictyostelium represents a novel
organismal model, to aid in further understanding the
normal physiological role of the presenilins and g-secre-
tase from a conserved and evolutionary point of view in
a system that has no Notch or APP equivalent [4]. To
study the g-secretase in Dictyostelium, strains were cre-










- nulls. It is important to note that
mutants of these genes in Dictyostelium are viable,
unlike the embryonic lethality seen in mammalian sys-
tems, and that mutants display a variety of phenotypic
defects during specific periods of development. More-
over, phylogenetic sequence analysis reveals that the
Dictyostelium presenilins are structurally similar to
human presenilin rather than the related signal peptidyl
proteases (Figure 2A-D), and a majority of mutations in
human PSEN causing early-onset FAD [28] are con-
served in Dictyostelium PSEN proteins [8].
The presenilin g-secretase complexes regulate cell
differentiation and phagocytosis in Dictyostelium
Cells deficient for ps1 did not show post-aggregative
developmental defects compared to cells deficient for
ps2 suggesting that in Dictyostelium,P S E N 1g-secretase
complexes may carry out different functional activities
than PSEN2 g-secretase complexes during specific
phases of the life cycle. This observation fits well with
the suggestion that that there may be several distinct
presenilin complexes that have different biological activ-
ities [29]. Wild type and ps1
- cells are able to complete




mutants not only form fewer fruiting bodies, but predo-
minantly arrest as abnormal intermediate structures
within the same time frame [8]. The authors also show
that in Dictyostelium g-secretase complexes function to
regulate cell differentiation as measured by cell-type
specific gene expression and firmly establish that prese-
nilin g-secretase activity is required in a cell-autono-
mous pathway that determines cell fate during
development [8]. Once again, these in vivo observations
support a large body of suggestive evidence for preseni-
lin g-secretase playing an essential role in cellular and
neuronal differentiation during neural development and
adult neurogenesis in mouse and zebrafish models
[30,31]. Cells deficient for g-secretase also display a
reduced ability for phagocytosis. Quantification of pha-
gocytic rates for the various mutant strains revealed that
cells lacking PSEN1 had highly reduced rates of phago-
cytosis, but this was not the case for ps2
- cells. The
described phagocytosis defect supports observations that
mammalian presenilins are present in lysosomal mem-
branes, but also strengthens the argument that distinct
presenilin complexes exist and have different biological
activities. Further to this, when wild type amoeba were
made to express a variant of human APP, the cells were
clearly able to process APP in a manner identical to
mammalian cells resulting in the differential production
of C-terminal fragments and Ab40/Ab42, the toxic frag-
ment believed to be the causative agent in AD (Figure
3).
This work demonstrates the evolutionary conservation
of this key regulatory enzyme. The most obvious value
stemming from this work for the study of presenilin
function are the possibilities for elucidating presenilin-
independent function(s) as wild-type presenilins are
required for proper protein degradation through the
autophagosome-lysosome system thereby implicating a
role for these proteins in autophagy [32]; secondly, the
exciting prospects surrounding the finding that proteoly-
tic processing of APP occurs in Dictyostelium exactly
the same way as has been shown animal cells. This find-
ing is important not only because it provides an excel-
lent system in which to test therapeutic agents that
target Ab production in vivo, but it is remarkable that
this enzyme, given the evolutionary distance between
Dictyostelium and humans, is capable of cleaving a non-
endogenous substrate to produce C-terminal fragments
and ratios of secreted Ab40/Ab42 identical to mamma-
lian systems. Knowledge gained about human diseases
including cancers from the use of yeast cannot be
denied, and with Dictyostelium, we also have an equally
genetically tractable organism that not only contains
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behaves much like an animal cell and further offers the
ability to study gene function under conditions of multi-
cellularity all in the same model. Even with the evolu-
tionary distance between humans and Dictyostelium one
might expect genes to play different roles, but with
regard to amyloidogenic processing of APP, this does
not appear to be the case. It should be mentioned that a
survey of the Dictyostelium genome does not readily
identify or predict the presence of either the known a-
secretase or b-secretase [4] and suggests the presence of
yet to be identified first-cleavage sheddases either
unique to Dictyostelium or potentially conserved across
metazoan species. Moreover, this model offers a
Figure 2 Dictyostelium PS proteins align with human presenilins.( A) Phylogenic comparison of amino acid sequences of Dictyostelium and
the human PS and signal peptidyl proteases (SPP) proteins. The Dictyostelium PS proteins cluster closely with human PS. (B-E) Sequence
alignments of functional domains of PS and SPP proteins. Similar amino acid residues are indicated in red. Residue alignment surrounding the N-
terminal enzymatic aspartate (*) is shown. Residue alignment surrounding the C-terminal enzymatic aspartate (*) is shown. Residue alignment
within the conserved, overlined PALP domain region. Permissions: McMains, V.C. et al. (2010). Dictyostelium possesses highly diverged presenilin/g-
secretase that regulates growth and cell-fate specification and can accurately process human APP: a system for functional studies of the
presenilin/g-secretase complex. Dis. Model. Mech. 3, pp. 581-594.
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date to study g-secretase function directly, free from the
multiple secondary effects that can arise from aberrant
proteolytic processing of more than 60 identified sub-
strates [33]. This study provides strong in vivo evidence
f o rp r e s e n i l i nf u n c t i o ni nr e g ulating phagocytosis, only
previously suspected in animal cell culture [34]. Lastly,
with the availability of Dictyostelium strains carrying
multiple loss-of-function mutations to the components
of the g-secretase, this model system allows for the
rapid systematic analysis of how specific mutations to
human presenilins might result in gain-of-function or
loss-of-function effects that can be readily assessed in
higher models. Further studies will be required to deter-
mine whether the mammalian PSEN gene can rescue
Dictyostelium ps1-null phenotypes and proteolytic pro-
cessing of human APP.
Higher organism and cellular models of Huntington’s
disease
Huntington’sd i s e a s e( H D )i saf a t a ln e u r o d e g e n e r a t i v e
disease [35] also known as Huntington’s chorea, that
affects muscle coordination from preferential loss of
efferent medium spiny neurons in the striatum of the
basal ganglia, leads to cognitive decline, dementia and
eventually death [36-38]. Genetic evidence suggests the
disease is caused by an unstable CAG trinucleotide
repeat within the coding region of the htt gene leading
to expansion (> 35) of glutamine (Q) residues near the
amino-terminus of the protein [35]. Mutant HTT con-
fers an unknown gain-of-function property to the pro-
tein, but might also impair normal protein function
[39]. Huntingtin is a large (350 kDa) alpha-solenoid
HEAT (huntingtin, elongation factor 3, the A subunit of
protein phosphatase 2A, and TOR1) repeat protein [40]
Figure 3 Dictyostelium have PS-dependent g-secretase activity that processes human APP to release Ab peptides.( A)S c h e m a t i c
showing various APP derived products and their respective sizes. (B) ΔN-APP, a truncated human APP expressed in transformed wild type (WT)
and ps1-null cells were analyzed for secreted levels of Ab40 and Ab42 peptides by quantitative ELISA. Fresh media and media conditioned by
native WT cells were used a negative controls. Bars indicate standard errors derived from two independent experiments, each with two
replicates. (C) Protein samples were collected from native and APP-expressing CHO cells untreated or treated with DAPT, from growing WT
Dictyostelium or WT, aph1-null and ps1/2-null Dictyostelium that express ΔN-APP. APP expression and processing was determined by immunoblot
assay using anti-APP C-terminus antibodies. Permissions: McMains, V.C. et al. (2010). Dictyostelium possesses highly diverged presenilin/g-secretase
that regulates growth and cell-fate specification and can accurately process human APP: a system for functional studies of the presenilin/g-
secretase complex. Dis. Model. Mech. 3, pp. 581-594.
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mal function of HTT, the nature of the polyQ mutation
which is expressed in both neuronal and non-neuronal
cells and how it contributes to pathogenesis still remains
unclear [41]. Although genetically precise mouse models
for HD have contributed significantly towards under-
standing HTT normal function, these mice are expen-
sive to create, to maintain and therefore difficult to
recapitulate results. Thus, defining the disease-produ-
cing ‘gain-of-function’ - either a polyglutamine-length
dependent increase or deregulation of a normal hunting-
tin activity or the introduction of a novel polyglutamine-
length dependent activity, will require an understanding
of the protein’s normal function(s).
A wide range of HD animal models are currently
available and have been used to investigate pathological
pathways, molecular targets, and potential therapeutics.
Invertebrates such as Drosophila melanogaster,n o n -
mammalian species (e.g., Danio rerio)a n dm a m m a l s ,
including mice, rats, sheep and non-human primates,
have been genetically engineered to model the HD
mutation. Although these systems are extremely impor-
tant tools to understand HD, a large majority of studies
focus upon the late end-stage disease symptoms and
thus offer minimal insight into early manifestation
including HTT normal function. The existence of HD
cell lines has been, to a finite degree, useful for the dis-
section of huntingtin function and assessment of poten-
tial therapeutic compounds [42,43]. Further, in vitro cell
lines often do not show overt defects suggesting they
are unable to reproduce the pathophysiological mechan-
isms induced by the mutant gene.
Many established model systems are based upon an
amino-terminal fragment that results in perturbation of
many cellular processes but these remove the polygluta-
mine tract from its normal protein context. Therefore,
one cannot understate that strategies are badly needed
to reveal full length huntingtin-dependent biochemical
processes that contribute to HD pathology. Because of
the evolutionary conservation of huntingtin, lower
organism systems offer an attractive and affordable
route that has yet to be exploited to understand hun-
tingtin function.
The identification of Dictyostelium huntingtin
The Dictyostelium genome was screened and found to
contain a single gene with sequence homology to
human huntingtin. Bioinformatic and phylogenetic ana-
lysis of the primary amino acid sequence placed the pro-
tein firmly within the huntingtin family, including size,
and the presence of numerous HEAT and HEAT-like
repeats. Dictyostelium mutants’ deficient for HTT cells
a r ev i a b l e ,u n l i k et h ee m b r y o n i cl e t h a l i t ys e e ni nh i g h e r
eukaryotes, but are fragile in that they display a number
of subtle phenotypes suggesting that HTT is involved in
a number of cellular processes [9]. We show that hun-
tingtin deficiency impacts upon osmoregulation, cation
homeostasis, cell motility, cell shape, chemotactic cAMP
relay, homotypic cell-cell adhesion, cell fate determina-
tion and cytokinesis in Dictyostelium [9,44]. Importantly,
these phenotypic deficits are greatly dependent upon the
environment in which the cells are placed which sug-
gests that HTT aids in translating extracellular signals
into cellular processes. These findings support the large
body of evidence that suggest in metazoa, huntingtin is
a multifunctional protein with roles in embryogenesis,
cell fate, cytoskeleton, apoptosis, vesicular and mito-
chondrial transport, iron homeostasis, autophagy, energy
metabolism and transcriptional regulation [39,41,45,46].
A major issue of concern is which, if any, of these func-
tions directly involve HTT or are secondary effects to
HTT deficiency or mutant HTT activity. The power
behind the Dictyostelium system is that it allows for the
identification of in vivo HTT functions at the level of
both single cells and a multi-cellular environment all in
the same organism with a biochemical and cellular
clarity to identify functions that directly depend on
HTT.
Dictyostelium cells deficient for huntingtin display cell
shape and cytoskeletal defects
When htt
- cells are placed under low ionic strength
phosphate buffer, the cells elicit a round phenotype
without membrane extensions, a reduction of F-actin at
the cortex of the cell and under hypoosmotic conditions
rapidly swell and undergo complete lysis within 5-6 h
[9]. This fits well with reports that mutant HTT in cells
from HD patients or when normal huntingtin levels are
reduced, cells display defective actin-remodeling under
conditions of stress [47] and consistent with mammalian
studies that huntingtin regulates neurological processes
including actin-rich dendritic spine formation and mem-
brane branching [48,49]. In vitro binding of the HTT N-
terminus to F-actin has been reported [50] and may
indicate a normal, perhaps transient, function for HTT
in the regulation of the actin cytoskeleton. Dictyostelium
provides a valuable tool to uncover mechanisms by
which HTT regulates actin-cytoskeleton responses.
Huntingtin modulates chemotaxis in Dictyostelium
The failure of htt
- cells to osmoregulate and sensitivity
to extreme hypoosmotic shock secondarily affects intra-
cellular ion homeostasis. As a consequence, unless spe-
cific cations (Ca
2+ or Mg
2+) are provided exogenously
htt
- cells appear unable to initiate cAMP-induced Ca
2
+-transients that may act in a feedback loop to positively
reinforce cAMP relay which impairs chemotaxis during
Dictyostelium development. Although the a role for
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malian systems, a consensus is gradually emerging that
the dyshomeostasis of Ca
2+ is an important factor in the
linkage of the HTT mutation to the onset and progres-
sion of the disease [51] and together suggest abnormal
Ca
2+ s i g n a l i n ga n do t h e rC a
2+ signaling proteins should
be explored further as an evolutionary conserved role
for HTT.
Huntingtin regulates cell fate during development in
Dictyostelium
It was shown that HTT modulates cell fate in Dictyoste-
lium (Figure 4). Using chimeras where cells are marked
with GFP, htt
- cells in the presence of wild type cells fail
to populate the prespore region of the slug, and as a
consequence do not become spores [9]. Cell fate defects
in huntingtin deficient cells have also been observed in
vertebrates. In zebrafish, reduced expression of hunting-
tin differentially targets development of telencephalic
neurons compared to mid- and hind-brain [52]. In
mouse chimeras, Hdh-/- cells preferentially colonize the
hypothalamus, midbrain, and hindbrain relative to the
telencephalon and the thalamus during early develop-
ment [53]. Thus, like these latter neuronal populations,
Dictyostelium cells require huntingtin for the proper
development of viable spores. Not surprisingly, the data
thus far do not provide a simple definition for a single
normal function for huntingtin, but, as huntingtin defi-
ciency in Dictyostelium produces pleiotropic effects, the
findings are consistent with the consensus from mam-
malian studies that huntingtin is a multifunctional pro-
tein that impacts upon many biochemical processes.
Figure 4 Huntingtin regulates prespore/spore differentiation cell-autonomously. (A) GFP was expressed in htt
- cells and their position in
chimeras with unlabelled wild type cells was monitored. GFP:htt
- cells fail to populate the prespore domain. (B) Reverse experiment in which
GFP: WT cells in chimeras with unlabelled htt
- cells occupy the prespore domain. The prestalk (pst) and prespore (psp) domains are underlined.
Cell types within each region are shown and slugs are arranged with the front facing towards the right. Permission: Myre M.A. et al. (2009).
Deficiency of huntingtin has pleiotropic effects in the social amoeba Dictyostelium discoideum. PLoS Genetics, 7(4), pp. e1002052.
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neating which of these functions are conserved in mam-
mals. Ultimately, determining to what degree these
functions are altered by expansion of the polyglutamine
tract in human huntingtin will provide much needed
insights into the mechanism by which mutant hunting-
tin triggers HD pathogenesis.
Insight into Hirano bodies - Dictyostelium discoideum
Hirano bodies, described about 40 years ago, are bright
eosinophilic intracytoplasmic inclusions/protein aggre-
gates with crystalloid fine rod structures that occur pre-
ferentially in the neuronal processes of individuals with
neurodegenerative diseases including Alzheimer’sd i s -
ease, Creutzfeldt-Jacob disease, amyotrophic lateral
sclerosis, parkinsonism-dementia and Pick’s disease
[54,55]. Hirano bodies are largely considered a patholo-
gical hallmark of postmortem brain samples from
patients suffering from neurodegenerative disorders
representing “tombstones” of neuronal cell death. Hir-
ano bodies have been reported in glial cells, in periph-
eral nerve axons and in extraocular muscles of eyes [56]
suggesting they are more than products of cell death. It
should be noted that Hirano bodies, as a function of
age, appear in individuals without neurodegeneration
[57]. Hirano bodies are complex inclusions comprised of
many proteins including actin and actin-associated pro-
teins (cofillin and alpha-actinin), tau, a C-terminal frag-
ment of APP; microtubule associated bundling proteins,
and neurofilaments [55]. Moreover, they have been
described in various experimental animals. Understand-
ing the underlying pathological molecular mechanism
responsible for their formation has been precluded by
the lack of either an in vitro or in vivo experimental
model system.
Research using Dictyostelium revealed that formation
of Hirano bodies is a pathological event [58]. The
expression in Dictyostelium of the CT fragment (amino
acids 124-295) of the 34 kDa protein, the 34 kDa pro-
tein is one of 11 actin crosslinking proteins present in
Dictyostelium, a protein that exhibits activated actin
binding and calcium-insensitive actin filament cross-
linking activity induced cells to form ellipsoidal para-
crystalline inclusions that contain ordered assemblies of
F-actin, CT-myc, myosin II, cofilin and alpha-actinin
that remarkably resembled the structure of Hirano
bodies. They extended their findings to mammalian
murine cells and discovered that F-actin rearrangements
caused by a reduction in stress fibers accumulate as
numerous punctate foci and large aggregates: Hirano
bodies [58]. So the failure to regulate either the activity
and/or affinity of an actin cross-linking protein provides
a signal that forms Hirano bodies. Whereas wild type
cells complete development in 24 h, CT-myc cells
contained significantly higher amounts of F-actin,
formed fruiting bodies with delayed developmental tim-
ing by ~6 h. The accumulation of F-actin was also
shown to occur in murine cells expressing CT-myc.
This report established for the first time that Hirano
bodies are not restricted to mammalian cells or nerve
cells occur because of aberrant function of the actin
cytoskeleton and that Hirano bodies can exert defects
on normal cell function. Because of using Dictyostelium,
Hirano bodies and induction of F-actin rearrangements
in mammalian cell cultures by expression of the CT 34-
kDa actin-bundling protein was found to occur in HEK
293, HeLa, Cos7 cells, neuroblastoma and astrocytic
cells, and in primary neurons [59].
Conclusion
Several Dictyostelium genes are homologous or retain a
significant amount of structural conservation to human
genes making the organism a useful biomedical model
system. With the entire genome sequenced and publicly
available in a model organism database called dictyBase,
it allows molecular and cellular biologists to examine
with more clarity the complex multifunctional aspects of
gene function. However, one limitation of using unicel-
lular organisms (e.g., yeast) as models for assessing the
function of genes involved in disease is that pathologies
which affect specific organs cannot be as readily
assessed as it might be in the relevant organism. This
limitation may also apply to genes that are present in
unicellular organisms but are required in a more strin-
gent manner in specialized tissues, or expressed as a
variety of different isoforms in specific cell types. How-
ever, this limitation has not precluded the use of lower
organisms to understand cell division and cancers in
many different organs. Although Dictyostelium develops
into bona fide multicellular organism, it does present a
limitation in the number of cell types that can be ana-
lyzed and therefore discoveries made using this organ-
ism must be rigorously assessed in the relevant
mammalian cell type. Coupled with translational experi-
ments and validation in higher eukaryotes, research
using Dictyostelium will expedite and contribute to our
understanding of human neurological diseases. Indivi-
dual cell behavior accounts for the many phases of
health and pathogenic mechanisms that initiate disease.
This has been elegantly portrayed in Dictyostelium with
respect to the precise production of Ab from the hetero-
logous expression of human APP. Chemotaxis is a criti-
cal cellular function with implications in embryogenesis.
Dictyostelium cells deficient for HTT show highly defec-
tive chemotactic behavior coupled with cytoskeletal/
membrane deficits under conditions of low ionic condi-
tions that may reveal conserved roles for this protein in
axon guidance, neuritic extensions and embryogenesis.
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tional research conducted in higher organisms or neuro-
nal cell models will be beneficial for understanding both
Dictyostelium cellular physiology and, more importantly,
the cellular mechanisms of human disease. I wish to
posit that multiple model systems can and should be
employed in the cross-genomic analysis of human neu-
rodegenerative disease genes to address multiple basic
eukaryotic cellular functions (e.g., Dictyostelium), to
their assembly into various types of more complex
molecular pathways (e.g., flies and worms), and then
validated and assessed in models of human neurodegen-
erative disease (e.g., mice).
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